Scarica l'app Stockscreener
2.38
0.42%
0.010
Pre-mercato:
2.39
0.01
+0.42%
Compugen Ltd Borsa (CGEN) Ultime notizie
Compugen to host virtual event on COM701 ovaria... - Pluang
Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026 - Yahoo Finance
Compugen Stock Price Forecast. Should You Buy CGEN? - StockInvest.us
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference - Eastern Progress
Compugen Shareholders Approve All Proposals at 2026 Annual Meeting - The Globe and Mail
All 2026 AGM proposals pass at Compugen (CGEN) - Stock Titan
Israel National Biotech Innovation Center Launches With Anat Cohen-Dayag as CEO of INBI Core - citybiz
Compugen to present at H.C. Wainwright Investme... - Pluang
A cancer treatment company will speak live Sept. 14. Compugen’s talk will be webcast. - Stock Titan
New initiative seeks $500m to commercialize Israeli life scienceGlobes - Globes - Israel Business News
Compugen (CGEN) Holds Near $2.62 as Shares Navigate Tight $2.49–$2.75 RangeRetracement Entry - dars.gov.et
All You Need to Know About Compugen (CGEN) Rating Upgrade to Buy - Yahoo Finance
Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Compugen (CGEN) Reports Q2 Loss, Misses Revenue Estimates - Eastern Progress
Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance
Compugen (CGEN) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Price Reaction: Shares Finish 1.28% Up on the DayCost Structure Review - dars.gov.et
Compugen (CGEN) Dips 2.49% to $2.35, Pressure Mounts Toward Support at $2.23Price Target - vinanet.vn
Analysts Have Just Cut Their Compugen Ltd. (NASDAQ:CGEN) Revenue Estimates By 14% - simplywall.st
CGEN Q2 2026 Earnings: Loss Narrower Than Expected as EPS Surprises PositivelyMargin Expansion Trends - vinanet.vn
Compugen Ltd. (CGEN) Slides 3.6% as Biotech Stock Approaches Key $2.29 SupportBuy Signal Reports - vinanet.vn
Compugen (NASDAQ:CGEN) Share Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Compugen (CGEN) Slips 1.8% to $2.46 as Shares Hover Near Key SupportSingle Stock ETF - Vinanet
Compugen (CGEN) Gains 4.17% to $2.50 as Immuno-Oncology Stock Shows ResiliencePSAR Stop - dars.gov.et
Compugen (CGEN) Q2 2026 Earnings Call Transcript - AOL.com
Compugen (CGEN) Slips 2.9% to $2.34 as Shares Approach Key Support at $2.22RVOL Spike - careplusvn.com
Compugen Ltd. (CGEN) stock price, news, quote and history - Yahoo Finance Singapore
Compugen Ltd (CGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Compugen Ltd (CGEN) Stock News Today - TradingKey
Compugen Ltd. (CGEN) Rises 2.17% to $2.35: Biotech Stock Holds Key Support as Resistance at $2.47 Looms - careplusvn.com
Compugen: Better Runway Ahead Of MAIA - Seeking Alpha
FY2026 EPS Estimates for Compugen Raised by HC Wainwright - MarketBeat
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ... By GuruFocus - Investing.com Canada
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancin - GuruFocus
Compugen stock maintained at Buy by H.C. Wainwright on trial data - Investing.com South Africa
H.C. Wainwright Maintains Compugen(CGEN.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Compugen Ltd. (NASDAQ:CGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Compugen (CGEN) Stock Holds Steady As Cash Runway Extends To 2029 - simplywall.st
CGEN Looks 54.6% Undervalued on GF Value™ - GuruFocus
Earnings call transcript: Compugen Q2 2026 revenue misses forecast as cash runway extends - Investing.com Canada
Compugen Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Compugen Q2 Earnings Call Highlights - TradingView
CGEN: Revenue doubled and clinical programs advanced, supporting a strong outlook into 2029 - TradingView
Compugen Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Compugen Ltd Earnings Call Transcript - GuruFocus
Compugen (NASDAQ: CGEN) seeks votes on directors, pay policy and auditor - Stock Titan
COMPUGEN ($CGEN) Releases Q2 2026 Earnings - Quiver Quantitative
Compugen (NASDAQ:CGEN) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Compugen (NASDAQ: CGEN) reports H1 2026 results, cash runway into 2029 - Stock Titan
Compugen Reports Second Quarter 2026 Results - Yahoo Finance
Compugen announces annual shareholder meeting - Bitget
Compugen's ovarian cancer trial on track with k... - Pluang
Compugen (CGEN) Edges Higher at $2.35 as Biotech Sentiment SteadiesUndervalued Stocks - dars.gov.et
Compugen Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView
CGEN Q2'26 Earnings: EPS estimate is (0.08) USD - TradingView
Compugen (CGEN) Surges 4.24% as Biotech Sentiment Lifts Small-Cap NamesPut Flow Alert - dars.gov.et
Form 4 COMPUGEN LTD For: 30 July By Investing.com - Investing.com Nigeria
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):